These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34642135)

  • 1. The impact of psoriasis on quality of life of children and their caregivers: an Italian experience.
    Bardazzi F; A Chessa M; Patrizi A; Iommi M; Rucci P; M Ali F; Filippi F; Tengattini V; Neri I
    Eur J Dermatol; 2021 Oct; 31(5):649-650. PubMed ID: 34642135
    [No Abstract]   [Full Text] [Related]  

  • 2. Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients.
    Bruins FM; Bronckers IMGJ; Groenewoud HMM; van de Kerkhof PCM; de Jong EMGJ; Seyger MMB
    JAMA Dermatol; 2020 Jan; 156(1):72-78. PubMed ID: 31774449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial.
    Langley RG; Paller AS; Hebert AA; Creamer K; Weng HH; Jahreis A; Globe D; Patel V; Orlow SJ
    J Am Acad Dermatol; 2011 Jan; 64(1):64-70. PubMed ID: 20619489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of quality of life in Turkish children with psoriasis and their caregivers.
    Tekin B; Gurel MS; Topkarci Z; Topaloglu Demir F; Aytekin S; Cebeci Kahraman F; Singer R; Erdemir VA; Uzuncakmak TK; Yasar S; Akdeniz N; Altunay IK; Kocaturk E; Turkoglu Z; Erdogan B
    Pediatr Dermatol; 2018 Sep; 35(5):651-659. PubMed ID: 29984848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of treatments in daily clinical practice on the Children's Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry.
    Oostveen AM; de Jager ME; van de Kerkhof PC; Donders AR; de Jong EM; Seyger MM
    Br J Dermatol; 2012 Jul; 167(1):145-9. PubMed ID: 22616669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy options for psoriasis in childhood and adolescence].
    Zappel K; Sterry W; Blume-Peytavi U
    J Dtsch Dermatol Ges; 2004 May; 2(5):329-42. PubMed ID: 16281521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
    Pescitelli L; Dini V; Gisondi P; Loconsole F; Piaserico S; Piccirillo A; Stinco G; Errichetti E; Talamonti M; Tripo L; Volpi W; Prignano F
    J Dermatol Sci; 2015 May; 78(2):149-51. PubMed ID: 25681953
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementation of Instrument Based on Eight Health Related Quality of Life Domains for Measuring of Willingness to Pay for Psoriasis Treatment.
    Dobrev HP; Atanasov NG; Dimitrova DD
    Folia Med (Plovdiv); 2017 Sep; 59(3):326-335. PubMed ID: 28976906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in body surface area is associated with better quality of life among patients with psoriasis in the Corrona Psoriasis Registry.
    Wu JJ; Schrader A; McLean RR; Valdecantos W; Etzel C; Singh R
    J Am Acad Dermatol; 2021 Jun; 84(6):1715-1717. PubMed ID: 32798582
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
    Gual A; Pau-Charles I; Molin S
    J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].
    Ortonne JP; Shear N; Shumack S; Henninger E;
    BMC Dermatol; 2005 Dec; 5():13. PubMed ID: 16359548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries.
    Ragnarson Tennvall G; Hjortsberg C; Bjarnason A; Gniadecki R; Heikkilä H; Jemec GB; Kragballe K; Miller IM; Svensson Å
    Acta Derm Venereol; 2013 Jul; 93(4):442-5. PubMed ID: 23138500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab.
    Hesselvig JH; Egeberg A; Loft ND; Zachariae C; Kofoed K; Skov L
    Acta Derm Venereol; 2018 Mar; 98(3):335-339. PubMed ID: 29110019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients.
    Caldarola G; De Simone C; Moretta G; Poscia A; Peris K
    J Dermatolog Treat; 2017 Dec; 28(8):722-725. PubMed ID: 28488449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).
    Salek MS; Finlay AY; Lewis JJ; Sumner MI
    Qual Life Res; 2004 Feb; 13(1):91-5. PubMed ID: 15058791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.
    Dubertret L; Mrowietz U; Ranki A; van de Kerkhof PC; Chimenti S; Lotti T; Schäfer G;
    Br J Dermatol; 2006 Oct; 155(4):729-36. PubMed ID: 16965422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatments for severe pediatric psoriasis: a practical approach.
    Marqueling AL; Cordoro KM
    Dermatol Clin; 2013 Apr; 31(2):267-88. PubMed ID: 23557655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tazarotene vs. coal tar in stable plaque psoriasis.
    Kumar U; Kaur I; Dogra S; De D; Kumar B
    Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis.
    DI Lernia V; Neri I; Calzavara Pinton P; DI Nuzzo S; Stingeni L; Guarneri C; Belloni Fortina A; Bonamonte D; Cambiaghi S; Lasagni C; Panzone M; Corazza M; Offidani A; Gisondi P
    G Ital Dermatol Venereol; 2017 Aug; 152(4):327-332. PubMed ID: 26761766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.